Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior

被引:20
作者
Perkins, P
Kemp, BL
Putnam, JB
Cox, JD
机构
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT RADIOTHERAPY,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PATHOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT THORAC SURG,HOUSTON,TX 77030
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1997年 / 20卷 / 03期
关键词
carcinoid tumor; lung neoplasms; prognostic factors;
D O I
10.1097/00000421-199706000-00016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinoid tumors of the lung are uncommon and usually have a favorable outcome after resection. However, some patients have aggressive tumors that cannot be completely resected or have unfavorable outcomes after resection. A retrospective study was conducted to identify factors that predict outcome. Records of all previously untreated patients treated at the University of Texas M. D. Anderson Cancer Center (UTMDACC) between 1959 and 1994, with histologically confirmed carcinoid tumors of the lung, were reviewed. Histologic specimens were reclassified by contemporary criteria. Five-year survival for 79 patients without distant metastasis who had tumors with clinically aggressive features at diagnosis (defined as extension to the carina, involvement of regional lymph nodes, and/or vascular invasion) was 50.9% as compared with 76.9% (p = 0.01) for patients without these features. Five-year survival was 38.7% for patients with ''atypical'' histopathology as compared with 78.9% for patients with ''typical'' histopathology (p = 0.01). Patients with aggressive tumors were more likely to have atypical tumors [odds ratio (OR) 11.73, p < 0.001]. However, 17.5% of the patients with clinically aggressive carcinoid tumors had tumors that were classified as typical. Carcinoid tumors of the lung that exhibit aggressive behavior may not have atypical histopathologic features. Clinical features that suggest aggressive behavior and unfavorable outcome warrant further investigation.
引用
收藏
页码:285 / 288
页数:4
相关论文
共 41 条
  • [31] Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
    Kim, Joo Young
    Brosnan-Cashman, Jacqueline A.
    An, Soyeon
    Kim, Sung Joo
    Song, Ki-Byung
    Kim, Min-Sun
    Kim, Mi-Ju
    Hwang, Dae Wook
    Meeker, Alan K.
    Yu, Eunsil
    Kim, Song Cheol
    Hruban, Ralph H.
    Heaphy, Christopher M.
    Hong, Seung-Mo
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1598 - 1606
  • [32] Lymphadenectomy for lung carcinoids: Which factors may predict nodal upstaging? A multi centric, retrospective study
    Chiappetta, Marco
    Lococo, Filippo
    Sperduti, Isabella
    Cusumano, Giacomo
    Terminella, Alberto
    Fournel, Ludovic
    Guerrera, Francesco
    Filosso, PierLuigi
    Tabacco, Diomira
    Nicosia, Samanta
    Alifano, Marco
    Gallina, Filippo
    Facciolo, Francesco
    Margaritora, Stefano
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 588 - 598
  • [33] Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers
    Xie, Dong
    Marks, Randolph
    Zhang, Mingrui
    Jiang, Gening
    Jatoi, Aminah
    Garces, Yolanda I.
    Mansfield, Aaron
    Molina, Julian
    Yang, Ping
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (08) : 1213 - 1220
  • [34] Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors
    Palazzo, Maxime
    Lombard-Bohas, Catherine
    Cadiot, Guillaume
    Matysiak-Budnik, Tamara
    Rebours, Vinciane
    Vullierme, Marie-Pierre
    Couvelard, Anne
    Hentic, Olivia
    Ruszniewski, Philippe
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (02) : 232 - 238
  • [35] Nested Cohort Study to Identify Characteristics That Predict Near-Term Disablement From Lung Cancer Brain Metastases
    Cheville, Andrea L.
    Basford, Jeffrey R.
    Pamey, Ian
    Yang, Ping
    Diehn, Felix E.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2017, 98 (02): : 303 - 311
  • [36] Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients
    Fathi, Amir H.
    Romanyshyn, Jonathan
    Barati, Mehdi
    Choudhury, Uzair
    Chen, Allen
    Sosa, Julie Ann
    AMERICAN SURGEON, 2020, 86 (05) : 458 - 466
  • [37] Location of CD39+ T cell subpopulations within tumors predict differential outcomes in non-small cell lung cancer
    Koppensteiner, Lilian
    Mathieson, Layla
    Pattle, Samuel
    Dorward, David A.
    O'Connor, Richard
    Akram, Ahsan R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [38] Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
    Shaverdian, Narek
    Veruttipong, Darlene
    Wang, Jason
    Schaue, Dorthe
    Kupelian, Patrick
    Lee, Percy
    CLINICAL LUNG CANCER, 2016, 17 (01) : 39 - 46
  • [39] Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis
    Chiappetta, Marco
    Leuzzi, Giovanni
    Sperduti, Isabella
    Bria, Emilio
    Mucilli, Felice
    Lococo, Filippo
    Filosso, Pier Luigi
    Ratto, Giovanni Battista
    Spaggiari, Lorenzo
    Facciolo, Francesco
    CLINICAL LUNG CANCER, 2020, 21 (05) : 464 - +
  • [40] A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer
    Zhu, Zhenchen
    Chen, Minjiang
    Hu, Ge
    Pan, Zhengsong
    Han, Wei
    Tan, Weixiong
    Zhou, Zhen
    Wang, Mengzhao
    Mao, Li
    Li, Xiuli
    Sui, Xin
    Song, Lan
    Xu, Yan
    Song, Wei
    Yu, Yizhou
    Jin, Zhengyu
    EUROPEAN RADIOLOGY, 2023, 33 (06) : 3918 - 3930